Hydroxyurea Suppliers & Bulk Manufacturers
Available Forms: Capsules and Tablets
Available Strengths: Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg
Reference Brands: Hydrea, Droxia , Siklos
Category: Anemia
Hydroxyurea is an oral cytoreductive drug used for sickle cell disease, CML, and polycythemia vera. Available in 100–500 mg strengths under brands like Hydrea, Droxia, and Siklos. Ideal for pharma B2B sourcing and global bulk supply. Hydroxyurea is available in Capsules and Tablets and strengths such as Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Hydroxyurea is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Hydroxyurea can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Hydroxyurea is a widely used oral chemotherapeutic and hematologic drug indicated for sickle cell disease, chronic myeloid leukemia (CML), polycythemia vera, and essential thrombocythemia. It works by inhibiting DNA synthesis and increasing fetal hemoglobin (HbF) in sickle cell patients. Marketed under brands like Hydrea, Droxia, and Siklos, it is available in 100 mg to 500 mg capsules and tablets. Manufactured under GMP standards, Hydroxyurea is ideal for pharmaceutical distributors, hospitals, and global B2B buyers. We offer competitive pricing, regulatory documentation, and reliable bulk supply. Contact us today for high-quality Hydroxyurea sourcing and international export support.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Hydroxyurea is used to treat sickle cell disease by increasing fetal haemoglobin levels and reducing painful crises. It is also used in certain cancers such as chronic myeloid leukaemia and in conditions like polycythaemia vera to reduce high blood cell counts.
It is made from a synthetic hydroxylated urea compound that works by inhibiting DNA synthesis in rapidly dividing cells and increasing fetal haemoglobin production.
Common trade names include Hydrea, Droxia, and Siklos.
It is manufactured by several companies globally, including Bristol Myers Squibb and various approved generic manufacturers.
The generic name is Hydroxyurea.
Brand names include Hydrea, Droxia, and Siklos.
It is manufactured in multiple countries by both innovator and generic pharmaceutical companies.
Related Products
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View Details
Ferumoxytol Injection
Strength:
30 mg/mL
Form: Injection
Reference Brands: Feraheme (USA)
View Details
Deferoxamine
Strength:
500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details
Deferasirox
Strength:
125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View DetailsQuick Response Guaranteed | Verified Suppliers
